» Articles » PMID: 32131483

Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Mar 6
PMID 32131483
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotropic viruses infect the central nervous system (CNS) and cause acute or chronic neurologic disabilities. Regulatory T cells (Treg) play a critical role for immune homeostasis, but may inhibit pathogen-specific immunity in infectious disorders. The present review summarizes the current knowledge about Treg in human CNS infections and their animal models. Besides dampening pathogen-induced immunopathology, Treg have the ability to facilitate protective responses by supporting effector T cell trafficking to the infection site and the development of resident memory T cells. Moreover, Treg can reduce virus replication by inducing apoptosis of infected macrophages and attenuate neurotoxic astrogliosis and pro-inflammatory microglial responses. By contrast, detrimental effects of Treg are caused by suppression of antiviral immunity, allowing for virus persistence and latency. Opposing disease outcomes following Treg manipulation in different models might be attributed to differences in technique and timing of intervention, infection route, genetic background, and the host's age. In addition, mouse models of virus-induced demyelination revealed that Treg are able to reduce autoimmunity and immune-mediated CNS damage in a disease phase-dependent manner. Understanding the unique properties of Treg and their complex interplay with effector cells represents a prerequisite for the development of new therapeutic approaches in neurotropic virus infections.

Citing Articles

Harnessing the Anti-Inflammatory Effects of Perinatal Tissue Derived Therapies for the Treatment of Inflammatory Skin Diseases: A Comprehensive Review.

Khalilzad M, Mohammadi J, Najafi S, Amirsaadat S, Zare S, Khalilzad M Stem Cell Rev Rep. 2024; 21(2):351-371.

PMID: 39531196 DOI: 10.1007/s12015-024-10822-3.


Correlates of disease severity in bluetongue as a model of acute arbovirus infection.

Herder V, Caporale M, MacLean O, Pintus D, Huang X, Nomikou K PLoS Pathog. 2024; 20(8):e1012466.

PMID: 39150989 PMC: 11357116. DOI: 10.1371/journal.ppat.1012466.


Understanding the Spectrum and Management of Post-Tuberculosis Lung Disease: A Comprehensive Review.

Yadav S, Rawal G Cureus. 2024; 16(6):e63420.

PMID: 39077302 PMC: 11284254. DOI: 10.7759/cureus.63420.


Balancing functions of regulatory T cells in mosquito-borne viral infections.

Sann S, Kleinewietfeld M, Cantaert T Emerg Microbes Infect. 2024; 13(1):2304061.

PMID: 38192073 PMC: 10812859. DOI: 10.1080/22221751.2024.2304061.


Balanced T and B cell responses are required for immune protection against Powassan virus in virus-like particle vaccination.

Stone E, Hassert M, Geerling E, Wagner C, Brien J, Ebel G Cell Rep. 2022; 38(7):110388.

PMID: 35172138 PMC: 8919300. DOI: 10.1016/j.celrep.2022.110388.


References
1.
Derfuss T, Segerer S, Herberger S, Sinicina I, Hufner K, Ebelt K . Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia. Brain Pathol. 2007; 17(4):389-98. PMC: 8095593. DOI: 10.1111/j.1750-3639.2007.00088.x. View

2.
Hollmann C, Werner S, Avota E, Reuter D, Japtok L, Kleuser B . Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4+ Conventional versus Foxp3+ Regulatory T Cells. J Immunol. 2016; 197(8):3130-3141. DOI: 10.4049/jimmunol.1600691. View

3.
Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

4.
Prasad S, Hu S, Sheng W, Singh A, Lokensgard J . Tregs Modulate Lymphocyte Proliferation, Activation, and Resident-Memory T-Cell Accumulation within the Brain during MCMV Infection. PLoS One. 2016; 10(12):e0145457. PMC: 4697843. DOI: 10.1371/journal.pone.0145457. View

5.
Eggers C, Arendt G, Hahn K, Husstedt I, Maschke M, Neuen-Jacob E . HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017; 264(8):1715-1727. PMC: 5533849. DOI: 10.1007/s00415-017-8503-2. View